Recombinant Human IL3RA Protein, DYKDDDDK-tagged
| Cat.No. : | IL3RA-151H |
| Product Overview : | Recombinant Human interleukin 3 receptor subunit alpha(IL3RA) protein, transcript variant 1(NM_002183), with a DYKDDDDK tag, was expressed in human cells. |
- Specification
- Gene Information
- Related Products
| Description : | This is a receptor for interleukin-3. |
| Source : | Human Cells |
| Species : | Human |
| Tag : | DYKDDDDK |
| Form : | Purified protein formulated in a sterile solution of TBS buffer, pH7.308, without any preservatives. |
| Molecular Mass : | 41.2 kDa |
| Endotoxin : | Endotoxin level is < 0.1 ng/µg of protein (<1EU /µg) |
| Purity : | >90% by SDS-PAGE gel and Coomassie Blue staining |
| Applications : | Antigens, Western, ELISA and other in vitro binding or in vivo functional assays, and protein-protein interaction studies. |
| Gene Name : | IL3RA interleukin 3 receptor, alpha (low affinity) [ Homo sapiens ] |
| Official Symbol : | IL3RA |
| Synonyms : | IL3RA; interleukin 3 receptor, alpha (low affinity); interleukin-3 receptor subunit alpha; CD123; IL-3RA; IL-3R-alpha; CD123 antigen; IL-3R subunit alpha; IL-3 receptor subunit alpha; IL-3 receptor alpha SP2 isoform; IL3R; IL3RX; IL3RY; IL3RAY; hIL-3Ra; MGC34174; |
| Gene ID : | 3563 |
| mRNA Refseq : | NM_002183 |
| Protein Refseq : | NP_002174 |
| MIM : | 308385 |
| UniProt ID : | P26951 |
Products Types
| ◆ Recombinant Protein | ||
| IL3RA-4517M | Recombinant Mouse IL3RA Protein, His (Fc)-Avi-tagged | +Inquiry |
| IL3RA-1120H | Recombinant Human IL3RA Protein (Met1-Arg305), HlgG1 Fc-tagged | +Inquiry |
| IL3RA-06H | Recombinant Human IL3RA Protein, C-Fc-Avi tagged, Biotinylated | +Inquiry |
| IL3RA-1176H | Recombinant Human IL3RA Protein, His (Fc)-Avi-tagged | +Inquiry |
| IL3RA-5184H | Active Recombinant Human IL3RA Protein, His/Flag/StrepII-tagged | +Inquiry |
| ◆ Lysates | ||
| IL3RA-742CCL | Recombinant Canine IL3RA cell lysate | +Inquiry |
| IL3RA-2433HCL | Recombinant Human IL3RA cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThe feasibility of personalized therapy depends on the specific disease type and patient situation, and more research is needed to determine the application of personalized therapy to Il3ra.
Il3ra has certain promise in clinical application, especially in the treatment of immune-related diseases.
Regulates the proliferation and differentiation of immune cells by binding to its interacting cytokine IL-3, and plays a role in regulating the function of the immune system.
Clinical trials of recombinant Il3ra have been conducted in different disease areas. At present, some early trials show its potential in the treatment of certain diseases, but more research is needed to verify its efficacy and safety.
The Il3ra can regulate the proliferation and differentiation of different types of immune cells in the immune system, thus affecting the function of the immune system.
Il3ra is generally well tolerated, but some minor side effects such as headache and nausea may occur. Serious side effects are rare.
Customer Reviews (3)
Write a reviewIt is highly specific, that is, it binds only to its receptor IL-3R, and it has high potential in fighting disease and drug discovery -
Depending on the need, different IL-3Rα variants or mutants can be customized through techniques such as genetic modification to achieve the production of their specific properties. -
IL-3rα, by binding to its receptor, plays an important role in regulating biological processes such as cell proliferation and differentiation, and its biological activity needs to be guaranteed and can be detected by biological identification and other methods. -
Ask a Question for All IL3RA Products
Required fields are marked with *
My Review for All IL3RA Products
Required fields are marked with *
Inquiry Basket
